BGXX (Bright Green) Total Liabilities: $6.12 Mil (As of Jun. 2024)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is Bright Green Total Liabilities?

Bright Green BGXX -2.56% Total Liabilities is $6.12 Mil as of Jun. 2024.

Bright Green's Total Liabilities for the quarter that ended in Jun. 2024 was $6.12 Mil.

Bright Green's quarterly Total Liabilities declined from Dec. 2023 ($6.44 Mil) to Mar. 2024 ($4.84 Mil) but then increased from Mar. 2024 ($4.84 Mil) to Jun. 2024 ($6.12 Mil).

Bright Green's annual Total Liabilities increased from Dec. 2021 ($0.56 Mil) to Dec. 2022 ($11.21 Mil) but then declined from Dec. 2022 ($11.21 Mil) to Dec. 2023 ($6.44 Mil).


Bright Green Total Liabilities Historical Data

* Premium members only.

The historical data trend for Bright Green's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Bright Green Total Liabilities Chart

Bright Green Annual Data
Trend Dec20 Dec21 Dec22 Dec23
Total Liabilities
0.68 0.56 11.21 6.44

Bright Green Quarterly Data
Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24
Total Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 11.57 8.73 6.44 4.84 6.12

Bright Green Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

Bright Green's Total Liabilities for the fiscal year that ended in Dec. 2023 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=6.236+(0.202+-5.5511151231258E-17
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit+NonCurrent Deferred Income Tax)
+0+0+0)
=6.44

Total Liabilities=Total Assets (A: Dec. 2023 )-Total Equity (A: Dec. 2023 )
=17.403-10.965
=6.44

Bright Green's Total Liabilities for the quarter that ended in Jun. 2024 is calculated as

Total Liabilities=Total Assets (Q: Jun. 2024 )-Total Equity (Q: Jun. 2024 )
=15.981-9.863
=6.12

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Total Liabilities →
What does a Total Liabilities of $6.12 Mil mean?
Bright Green (BGXX) has a Total Liabilities of $6.12 Mil as of Jun. 2024. The total amount of liabilities as recorded on a company's balance sheet. View historical data for Bright Green and its competitors.
Is Bright Green's Total Liabilities too high?
Bright Green's current Total Liabilities is $6.12 Mil.
How does Bright Green's Total Liabilities compare to BFRI and AYTU?
Bright Green's Total Liabilities of $6.12 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Liabilities for a Drug Manufacturers company?
A good Total Liabilities depends on the Drug Manufacturers industry context. However, Total Liabilities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Liabilities mean?
A high Total Liabilities can signal that a stock is expensive relative to its fundamentals. The total amount of liabilities as recorded on a company's balance sheet. View historical data for Bright Green and its competitors. Bright Green's current Total Liabilities is $6.12 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Bright Green stock overvalued right now?
Bright Green (BGXX) has a current Total Liabilities of $6.12 Mil. The current Total Liabilities is $6.12 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Liabilities calculated?
Total Liabilities is calculated from a company's financial statements. For Bright Green (BGXX), the current Total Liabilities is $6.12 Mil as of Jun. 2024. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Bright Green Business Description

Address 1033 George Hanosh Boulevard, Grants, NM, USA, 87020
Bright Green Corp is a provider of cannabis, cannabis-related products, and other legal medicinal plant-based therapies, manufactured for research and pharmaceutical applications, as well as being an active ingredient in consumer-based solutions. The company plans to focus on the development of cannabis strains and sales of products with high contents of CBN (cannabinol) and CBG (cannabigerol).